临床评价报告：替诺福韦阿拉芬胺（Vemlidy）:( Gilead Sciences Can

StephenW

Clinical Review Report: Tenofovir Alafenamide (Vemlidy): (Gilead Sciences Canada, Inc.): Indication: Treatment of chronic hepatitis B in adults with compensated liver disease [Internet].
Source

Ottawa (ON): Canadian Agency for Drugs and Technologies in Health; 2018 Apr.
CADTH Common Drug Reviews.
Excerpt

The objective of this report was to perform a systematic review of the beneficial and harmful effects of tenofovir alafenamide for the treatment of adults with chronic hepatitis B (CHB) and compensated liver disease.

Copyright © 2018 Canadian Agency for Drugs and Technologies in Health.
Sections

    Abbreviations
    Executive Summary
    Introduction
    Objective and Methods
    Results
    Discussion
    Conclusions
    Appendix 1. Patient Input Summary
    Appendix 2. Literature Search Strategy
    Appendix 3. Excluded Studies
    Appendix 4. Detailed Outcome Data
    Appendix 5. Validity of Outcome Measures
    Appendix 6. Summary of Open-Label Studies
    Appendix 7. Summary of Natural History, Diagnosis, Management, and Prognosis of HBV
    References

PMID:
    30475544

Free Books & DocumentsFree full text

StephenW

临床评价报告：替诺福韦阿拉芬胺（Vemlidy） Gilead Sciences Canada，Inc。）：适应症：治疗患有代偿性肝病的成人的慢性乙型肝炎[互联网]。
资源

渥太华（加拿大）：加拿大卫生部药品和技术局; 2018年4月
CADTH常见药物评论。
摘抄

本报告的目的是对替诺福韦艾拉酚胺治疗成人慢性乙型肝炎（CHB）和代偿性肝病的有益和有害影响进行系统评价。

版权所有©2018加拿大卫生部药品和技术机构。
第

    缩略语
    执行摘要
    介绍
    目标和方法
    结果
    讨论
    结论
    附录1.患者输入摘要
    附录2.文献检索策略
    附录3.排除的研究
    附录4.详细的结果数据
    附录5.结果测量的有效性
    附录6.开放标签研究摘要
    附录7. HBV的自然史，诊断，管理和预后摘要
    参考

结论：
    30475544

免费书籍和文件免费全文

StephenW

https://www.ncbi.nlm.nih.gov/boo ... shelf_NBK533926.pdf